Figure 3From: Phosphorylated EGFR expression may predict outcome of EGFR-TKIs therapy for the advanced NSCLC patients with wild-type EGFR Progression-free survival curves according to epidermal growth factor receptor mutational status (A), phosphorylated tyrosine (pTyr) 1068 expression (B), pTyr1173 expression (C). Back to article page